Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

2626
1
FOSTER L B CO L.B. Foster Reports Strong Profitability Recovery in Q3 2024 Despite Sales Decline

Via official filing (AI summary) | 17 days ago | 0 comments

2627
1
Aldeyra Therapeutics, Inc. Aldeyra Therapeutics Reports Significant Financial Challenges, Net Loss of $15.1M in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2628
1
PIPER SANDLER COMPANIES Piper Sandler Reports 23.6% Revenue Growth and Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2629
1
Montrose Environmental Group, Inc. Montrose Environmental Group Reports 6.4% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2630
1
Gossamer Bio, Inc. Gossamer Bio Reports Significant Revenue Growth and Improved Operating Performance in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2631
1
Permian Resources Corp Permian Resources Corporation Reports 60% Revenue Growth and Significant Net Income Increase in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2632
1
PROVIDENT FINANCIAL HOLDINGS INC Provident Financial Holdings Reports 8% Net Income Growth, Strong Loan Origination in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2633
1
HAIN CELESTIAL GROUP INC The Hain Celestial Group Reports Decline in Net Sales and Net Loss in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2634
1
Spyre Therapeutics, Inc. Spyre Therapeutics Reports Financial Results for Q3 2024, Net Loss of $69M

Via official filing (AI summary) | 17 days ago | 0 comments

2635
1
Cadrenal Therapeutics, Inc. Cadrenal Therapeutics Reports Significant Financial Decline in Q3 2024, Net Loss Increases

Via official filing (AI summary) | 17 days ago | 0 comments

2636
1
Vor Biopharma Inc. Vor Biopharma Reports Improved Financials, Advances Clinical Programs, and Faces Nasdaq Compliance Challenge

Via official filing (AI summary) | 17 days ago | 0 comments

2637
1
YUM BRANDS INC Yum! Brands Reports Mixed Q3 2024 Results with 7% Revenue Growth, Net Income Decline

Via official filing (AI summary) | 17 days ago | 0 comments

2638
1
RESEARCH FRONTIERS INC Research Frontiers Reports 94% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2639
1
LIGHTPATH TECHNOLOGIES INC LightPath Technologies Reports 4% Revenue Growth, Net Loss in Q1 FY2025

Via official filing (AI summary) | 17 days ago | 0 comments

2640
1
Carter Bankshares, Inc. Carter Bankshares Reports Mixed Q3 Results, Net Income Up 55% Year-Over-Year

Via official filing (AI summary) | 17 days ago | 0 comments

2641
1
FIRST FINANCIAL BANCORP /OH/ First Financial Bancorp Reports Mixed Q3 2024 Results, Assets and Loans Grow Amid Profitability Challenges

Via official filing (AI summary) | 17 days ago | 0 comments

2642
1
Cars.com Inc. Cars.com Reports Mixed Q3 Results with Revenue Growth, Decreased Operating Income

Via official filing (AI summary) | 17 days ago | 0 comments

2643
1
INTERNATIONAL BANCSHARES CORP International Bancshares Corporation Reports 5.5% Asset Growth, 3.4% Net Income Decline in Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2644
1
Tecnoglass Inc. Tecnoglass Reports Strong Q3 and 9M 2024 Financials with Revenue and Profit Growth

Via official filing (AI summary) | 17 days ago | 0 comments

2645
1
Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals Reports Financial Changes Following Merger with Legacy OnKure

Via official filing (AI summary) | 17 days ago | 0 comments

2646
1
Wheeler Real Estate Investment Trust, Inc. Wheeler REIT Reports Mixed Q3 Results, Net Loss, and Increased Cash and Cash Equivalents

Via official filing (AI summary) | 17 days ago | 0 comments

2647
1
SIMMONS FIRST NATIONAL CORP Simmons First National Corporation Reports Mixed Q3 Results, Decline in Profitability Amid Increased Credit Risk

Via official filing (AI summary) | 17 days ago | 0 comments

2648
1
Vera Therapeutics, Inc. Vera Therapeutics Reports Significant Financial Developments, Increased Losses Amid Clinical Trial Spending

Via official filing (AI summary) | 17 days ago | 0 comments

2649
1
Janover Inc. Janover Inc. Reports 6% Revenue Growth, Mixed Financial Results for Q3 2024

Via official filing (AI summary) | 17 days ago | 0 comments

2650
1
Bluejay Diagnostics, Inc. Bluejay Diagnostics Reports Improved Financials, Reduced Losses, and Advancements in Symphony Technology Platform

Via official filing (AI summary) | 17 days ago | 0 comments